RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 144 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $191,368,754 | +83188.2% | 24,820,850 | +14.9% | 0.20% | -16.0% |
| Q3 2022 | $229,767 | +30.6% | 21,594,693 | -0.1% | 0.24% | +31.7% |
| Q2 2022 | $175,871 | +11.7% | 21,605,685 | -1.7% | 0.18% | +63.6% |
| Q1 2022 | $157,388 | -58.5% | 21,981,604 | -0.6% | 0.11% | -47.1% |
| Q4 2021 | $378,969 | -25.3% | 22,123,155 | +0.3% | 0.21% | -21.8% |
| Q3 2021 | $507,632 | -24.9% | 22,061,374 | +19.1% | 0.27% | -19.1% |
| Q2 2021 | $676,017 | – | 18,521,000 | – | 0.33% | – |
Download | ||||||